Multifocal atrial tachycardia: mechanisms, clinical correlates, and treatment.
MAT is an uncommon arrhythmia most often seen in elderly patients with chronic pulmonary disease who are critically ill due to acute respiratory or cardiac decompensation. Its importance lies in the fact that it is commonly mistaken for AF, since both disorders are characterized by narrow ventricular complexes, irregular rates, and (depending on the ECG lead observed in MAT) by an apparent lack of P wave activity. This may lead to treatment with digoxin, a drug known to be ineffective in the therapy of MAT, with the potential for producing toxicity in patients who are predisposed. The incidence of MAT in hospitalized patients in various studies ranges from 0.13% to 0.40%. The mechanism of the arrhythmia is thought to be triggered activity arising from increased intracellular calcium stores that may be produced by hypokalemia, hypoxia, acidemia, and increased catecholamines, characteristics commonly found in patients with MAT. COPD, coronary artery disease, CHF, and infection (both pulmonary and nonpulmonary) are the most common clinical settings of MAT. Mortality is very high in all patients studied, ranging from 38% to 62%, and is due to their underlying disease processes and not to the arrhythmia. The need for intubation and mechanically assisted ventilation portends a particularly poor prognosis for survival. Treatment should initially consist of correction of the precipitating causes, as it is common for patients to convert to sinus rhythm both spontaneously and after these measures are taken.(ABSTRACT TRUNCATED AT 250 WORDS)
Scher
D L
DL
State University Health Science Center, Brooklyn, N.Y.
Arsura
E L
EL
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D005260:Female; D006329:Heart Conduction System / Q000503:physiopathology*; D006801:Humans; D008297:Male; D013617:Tachycardia, Supraventricular / Q000188:drug therapy / Q000503:physiopathology; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D014700:Verapamil